Mitochondrial respiratory chain (MRC) (MRC)

The mitochondrial respiratory chain (MRC), frequently termed the mitochondrial proton pump, is a fundamental metabolic system composed of four primary enzyme complexes (I-IV) and the ATP synthase (Complex V) located within the inner mitochondrial membrane [1.1.1, 1.4.1]. These complexes facilitate oxidative phosphorylation by transferring electrons from donors like NADH and FADH2 to oxygen, a process coupled with the active transport of protons from the mitochondrial matrix into the intermembrane space [1.4.4, 1.4.5]. This proton pumping generates an electrochemical gradient, or proton-motive force, which is subsequently harnessed by ATP synthase to produce ATP, the cell's primary energy source [1.1.3, 1.4.2]. In clinical pharmacology, the MRC is a critical target; for example, the anti-diabetic drug metformin inhibits Complex I to modulate cellular energy balance, while other agents like atovaquone target Complex III for antimicrobial effects [1.3.4, 1.4.1]. Dysregulation of these proton-pumping mechanisms is central to the pathophysiology of mitochondrial diseases, neurodegenerative disorders, and the metabolic shifts seen in cancer, making the MRC a focal point for both therapeutic development and the assessment of drug-induced mitotoxicity [1.2.1, 1.5.1].

Other names

Mitochondrial proton pumpElectron transport chain (ETC)OXPHOS systemMitochondrial electron transport chainMitochondrial proton-translocating complexesNicotinamide nucleotide transhydrogenase (NNT)

Inhibition of electron transport chain complexes (I, III, IV), uncoupling of the mitochondrial proton gradient, and inhibition of the F-type ATPase (Complex V).